Ultra Seal Recalls Extra Strength Headache Relief Tablets for Stability Failures
Ultra Seal Corporation is recalling 701,735 packets of Extra Strength Headache Relief tablets due to out-of-specification results for salicylic acid.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which is defined as unlikely to cause adverse health consequences. The issue is a stability specification failure without reported injuries.
Plain-English summary
Ultra Seal Corporation is recalling 701,735 packets of Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets. The product was manufactured for Convenience Valet in Glendale Heights, IL. The recall was initiated because out-of-specification (OOS) results were observed for salicylic acid, an aspirin-related compound, indicating failed stability specifications.
The affected product was shipped to two distributors in Illinois and Texas. These distributors may have further repackaged and distributed the product. The recall includes specific lot numbers with expiration dates ranging from December 2020 to April 2022, including lots K-8909, AK8909, AK9507, AK9072, AK9102, AK9601, AK9679, AK9145, K9145, AK9743, AK9830, AK9276, AK9391, A9392, AK9505, AK9508, and AK9509.
Consumers should check their medication for the lot numbers and expiration dates listed above. If they possess the recalled product, they should stop using it and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablet packets, Manufactured for: Convenience Valet Glendale Heights, IL 60139,
- Manufacturer
- Ultra Seal Corporation
- Affected units
- 701,735
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: K-8909
- AK8909
- Exp. Date 12/2020
- AK9507
- Exp. Date 03/2021
- AK9072
- Exp. Date 04/2021
- AK9102
- AK9601
- AK9679
- Exp. Date 05/2021
- AK9145
- K9145
- Exp. Date 06/2021
- AK9743
- AK9830
- Exp. Date 07/2021
- AK9276
- Exp. Date 09/2021
- AK9391
Distribution
Part of a larger recall action
This product is one of 2 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Tablet with Acetaminophen Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 2 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateCiclopirox shampoo recalled after failing impurity specifications at eighteen months
FDA (Drugs) · 2025-12-24